Fundz

Pulmotect, Inc. reported raising $3.5 Million in an initial SEC Form D filing, from an offering of $3.5 Million

PRIVATEMar 11, 2021

Amount Raised

$3.5 Million

$3.5 Million sold, per SEC Form D (first sale Mar 11, 2021)

Round Type

Seed

HoustonBiotechnology

Quick answer

Pulmotect raised $3.5 Million in a Seed round, dated March 11, 2021. Pulmotect is based in Houston, Texas, United States.

How much did Pulmotect raise?
Pulmotect raised $3.5 Million in a Seed round on March 11, 2021.
What does Pulmotect do?
Pulmotect has developed PUL-042, an inhaled therapeutic which aims to boost the body's innate immune system resulting in highly-targeted lung protection against all major classes of pathogens including bacteria, fungi,..
Where is Pulmotect based and how big is it?
Pulmotect is based in Houston, Texas, United States.
Who are the decision-makers at Pulmotect?
Fundz holds 1 contact at Pulmotect, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Pulmotect that raised within 45 days of this round, from Fundz verified event records.

  • MED-X raised $225K on April 23, 2021.
  • GPB Scientific, LLC raised $17M on April 23, 2021.
  • BioCircuit Technologies raised $3.1M (Seed) on April 23, 2021.
  • BioCircuit Technologies raised $1.5M (Seed) on April 23, 2021.
  • Promedix, Inc. raised $250K on April 23, 2021.
  • ViaCyte Inc. raised $54M on April 22, 2021.

Who to call at Pulmotect, and when

A new round usually means Pulmotect is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Pulmotect raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pulmotect, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pulmotect. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pulmotect

Location

3900 ESSEX LANE

Houston, Texas, United States

About

Pulmotect has developed PUL-042, an inhaled therapeutic which aims to boost the body's innate immune system resulting in highly-targeted lung protection against all major classes of pathogens including bacteria, fungi, and viral pathogens.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pulmotect raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsBrenton S., Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Pulmotect's next move

See what Strategic adds

Pulmotect raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.